For instance, shikonin inhibits thioredoxin reductase 1 (TRXR1), thereby inhibiting the reduction of GSSG to GSH, causing apoptosis of gefitinib-resistant lung cancer cells [98]. Here, TXNRD1 is linked to lung carcinoma.